A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan

Vaccine

Volumn 31, Issue 15, 2013, Pages 1987-1993

  Habib, M A ^a   Soofi, S ^a   Ali, N ^a   Sutter, R W ^b   Palansch, M ^c   Qureshi, H ^d   Akhtar, T ^e   Molodecky, N A ^b   Okayasu, H ^b   Bhutta, Zulfiqar A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Pakistan Medical and Research Council   (Pakistan)

^e KHYBER MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Poliomyelitis; Risk factors; Seroconversion; Vaccine

Indexed keywords

ORAL POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ARTICLE; CHILD; DEMOGRAPHY; DIARRHEA; EDUCATION; FEMALE; GEOGRAPHY; HUMAN; INFANT; MALE; PAKISTAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE; SOCIOECONOMICS; STUNTING; VACCINATION;

ANTIBODIES, VIRAL; ANTIBODY FORMATION; DIARRHEA; DISEASE ERADICATION; DISEASE OUTBREAKS; EDUCATIONAL STATUS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; PAKISTAN; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; VACCINATION;

EID: 84875236697     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.003     Document Type: Article

References (41)

1. World Health Organization: Global Polio Eradication Initiative: Strategic Plan 2010-12.
2. World Health Organization: National Surveillance Bulletin Pakistan. 2011.
3. CDC Morbidity and Mortality Weekly Report: Progress toward poliomyelitis eradication, Afghanistan and Pakistan, 2008. 2009(58):198-201.
4. World Health Organization: Global Polio Eradication Initiative: Annual Report 2010. WHO, Geneva (WHO/Polio/11.02). 2010.
5. O'Reilly K.M., Durry E., ul Islam O., Quddus A., Abid N., Mir T.P., et al. The effect of mass immunization campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis. Lancet 2012, 380:491-498.
6. World Health Organization: weekly epidemiological record. 2012.
7. World Health Organization: Surveillance Report. 2011.
8. World Health Organization: weekly epidemiological record. Flood response in Pakistan bulletin. 2010;1(10).
9. Aga Khan University & UNICEF: National Nutritional Survey of Pakistan. 2011. Islamabad.
10. Caidi H., Bennis I.F., Mouan N., El Aouad R. Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco. East Mediterr Health J 2004, 10(July-September (4-5)):474-481.
11. Moore S.E., Goldblatt D., Bates C.J., Prentice A.M. Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children. Acta Paediatr 2003, 92(2):170-176.
12. Chandra R.K. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children. BMJ 1975, 2(5971):583-585. 1975-06-14 00:00:00.
13. AFP/polio case count. Global Polio Eradication Initiative. WHO, Geneva []. http://www.who.int/immunizationmonitoring/en/diseases/poliomyelitis/case_count.cfm.
14. Mushtaq M.U., Majrooh M.A., Ullah M.Z., Akram J., Siddiqui A.M., Shad M.A., et al. Are we doing enough? Evaluation of the Polio Eradication Initiative in a district of Pakistan's Punjab province: an LQAS study. BMC Public Health 2010, 10(1):60.
15. Nishtar S. Pakistan, politics and polio. Bull World Health Organ 2010, 88:159-160.
16. Birmingham M.E., Linkins R.W., Hull B.P., Hull H.F. Poliomyelitis surveillance: the compass for eradication. J Infect Dis 1997, 175(February (Suppl. 1)):S146-S150.
17. World Health Organization: The Polio Pipeline []. 2008(2). http://www.polioeradication.org/Portals/0/Document/Research/PolioPipeline/PolioPipeline_02.pdf.
18. El-Sayed N., Al-Jorf S., Hennessey K.A., Salama M., Watkins M.A., Abdelwahab J.A., et al. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt. Vaccine 2007, 25(27):5062-5070.
19. World Health Organization Polio eradication: surveys of routine immunization coverage and seroprevalence against polioviruses, Yogyakarta Province, Indonesia. Wkly Epidemiol Rec 2008, 5(83):45-48.
20. WHO guidelines on drawing blood: best practices in phlebotomy. Printed by the WHO Document Production Services, Geneva, Switzerland.
21. World Health Organization. Guidelines for WHO/EPI collaborative studies on Poliomyelitis. Standard procedures for determining immunity to polio virus using the microneuterlization test. WHO/EPI/GEN/93.9.
22. Kiffer C.R.V., Conceição O.J., Santos E.B., Sabino E., Focaccia R. Estimated prevalence of immunity to poliomyelitis in the city of São Paulo, Brazil: a population-based survey. Braz J Infect Dis 2002, 6:232-243.
23. Vancelik S., Guraksin A., Ayyildiz A., Beyhun N.E. Seroepidemiology of poliovirus antibody among children in Eastern Turkey. Indian J Med Res 2007, 126:528-533.
24. Sutter RW, Kew OM, and Cochi, SL 2004. Poliovirus vaccine-live. In: Plotkin SA, Orenstein WA (Eds). Vaccines (4th Edition, Chapter 25). Philadelphia, PA: W.B. Saunders Company.
25. El Bassioni L., Barakat I., Nasr E., de Gourville E.M., Hovi T., Blomqvist S., et al. Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am J Epidemiol 2003, 158(October (8)):807-815.
26. Sutter R.W., Patriarca P.A., Suleiman A.J., Pallansch M.A., Zell E.R., Malankar P.G., et al. Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol 1993, 22(October (5)):936-944.
27. Patriarca P.A., Wright P.F., John T.J. Factors affecting immunogenicity of oral polio vaccine in developing countries: a review. Rev Infect Dis 1991, 13:926-939.
28. Owais A., Hanif B., Siddiqui A.R., Agha A., Zaidi A.K.M. Does improving maternal knowledge of vaccines impact infant immunization rates? A community-based randomized-controlled trial in Karachi, Pakistan. BMC Public Health 2011, 11:239.
29. Shah M., Khan M.K., Shakeel S., Mahmood F., Sher Z., Sarwar M.B., et al. Resistance of polio to its eradication in Pakistan. Virol J 2011, 8(457). 10.1186/1743-422X-8-457.
30. Government of Pakistan, Pakistan Demographic and Health Survey.
31. Schreuder B., Kostermans C. Global health strategies versus local primary health care priorities-a case study of national immunisation days in Southern Africa. S Afr Med J Suid-Afrikaanse Tydskrif Vir Geneeskunde 2001, 91(March (3)):249-254.
32. Sack D.A., Qadri F., Svennerholm A.M. Determinants of responses to oral vaccines in developing countries. Ann Nestlé (Engl Ed) 2008, 66(2):71-79.
33. Triki H., Abdallah M.V., Ben Aissa R., Bouratbine A., Ben Ali Kacem M., Bouraoui S., et al. Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants. Vaccine 1997, 15(July (10)):1123-1129.
34. John T.J., Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol 1972, 96(October (4)):263-269.
35. Posey D.L., Linkins R.W., Oliveria M.J., Monteiro D., Patriarca P.A. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 1997, 175(February (Suppl. 1)):S258-S263.
36. Myaux J.A., Unicomb L., Besser R.E., Modlin J.F., Uzma A., Islam A.M., et al. Effect of diarrhea on the humoral response to oral polio vaccination. Pediatr Infect Dis J 1996, 15(March (3)):204-209.
37. Bahl R., Bhandari N., Wahed M.A., Kumar G.T., Bhan M.K. Group WCI-LVA. Vitamin A supplementation of women postpartum and of their infants at immunization alters breast milk retinol and infant vitamin A status. J Nutr 2002, 132(November (11)):3243-3248.
38. Savy M., Edmond K., Fine P.E., Hall A., Hennig B.J., Moore S.E., et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr 2009, 139(November (11)):2154S-2218S.
39. Certification of poliomyelitis eradication - European Region. Morb Mortal Wkly Rep. 2002; 51:572-574.
40. World Health Organization: Polio News Eradication [. 2002(16). http://www.who.int/vaccinesdocuments/docs/PDF02/polio6.pdf.
41. Schoub B.D., McAnerney J.M., van Middelkoop A., Blackburn N.K., Labadarios D. A population-based seroprevalence study in South Africa as a tool in the polio eradication initiative. Am J Trop Med Hyg 1998, 58(May (5)):650-654.